Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.
about
Microparticles as Biomarkers of Blood Coagulation in CancerThe potential of tumor-derived exosomes for noninvasive cancer monitoringThe central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: a reviewCancer and venous thromboembolic disease: from molecular mechanisms to clinical management.Exosomes and microvesicles: identification and targeting by particle size and lipid chemical probes.Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk.Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury.Inactivation of factor VIIa by antithrombin in vitro, ex vivo and in vivo: role of tissue factor and endothelial cell protein C receptor.Physical characterization and profiling of airway epithelial derived exosomes using light scattering.Biological properties of extracellular vesicles and their physiological functions.The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.Simulated Thrombin Generation in the Presence of Surface-Bound Heparin and Circulating Tissue FactorTissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation.Venous thrombosis and cancer: from mouse models to clinical trials.Coagulation activation in sickle cell trait: an exploratory studyIL-13 Augments Compressive Stress-Induced Tissue Factor Expression in Human Airway Epithelial CellsRoutine Hemostasis and Hemogram Parameters: Valuable Assessments for Coagulation Disorder and Chemotherapy in Cancer Patients.Cancer and Thrombosis: The Platelet Perspective.Small but mighty: microparticles as mediators of tumor progression.Toward routine detection of extracellular vesicles in clinical samples.Neutrophil derived microvesicles: emerging role of a key mediator to the immune response.Extracellular vesicles in hematological disorders.Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational DayRole of exosomes and microvesicles in hypoxia-associated tumour development and cardiovascular disease.Cancer-associated pathways and biomarkers of venous thrombosis.Extracellular Vesicles in Brain Tumor Progression.Neutrophil extracellular traps: protagonists of cancer progression?Analysis of the potential of cancer cell lines to release tissue factor-containing microvesicles: correlation with tissue factor and PAR2 expression.PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells.A review of the venous thrombotic issues associated with multiple myeloma.Microparticles as biomarkers of venous thromboembolic events.Screening for Malignancy in Patients With Unprovoked Venous Thromboembolism.An exploratory look at NETosis in atherosclerosis.Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: a role for circulating microparticles?Neutrophil derived microparticles increase mortality and the counter-inflammatory response in a murine model of sepsis.Thrombosis and platelets: an update.Tumor vascular infarction: prospects and challenges.Much More than Trousseau Syndrome. The Broad Spectrum of the Pancreatic Paraneoplastic Syndromes.
P2860
Q26783691-D340621B-E01A-4D6F-AD0C-85CB37F76B51Q26796396-062B6174-A12C-4DF3-B7A7-CF4AD2E30C64Q27021748-B8FE43A9-738D-41EF-844B-BF40147F15BFQ33763866-9C4980F9-913A-45EF-A2EE-EAC45BA5E829Q33903545-4478BFC0-4107-48E7-9EA9-108FA81B2307Q34657739-602561DE-7550-4D34-9F8E-49F8E196083BQ35025682-CBAD7E03-B512-4339-B80D-E70BBC64008CQ35220670-BA08B6F0-E9D1-4D1D-B719-C5895E39B60BQ35221091-C7C02D2B-871D-4A79-8784-38DF51DAB597Q35590488-131F56A5-E33D-403C-A438-B1175EC5C093Q35611763-87EAF44C-FD50-4D7E-A9E0-6045970C710AQ36051099-E1A373E0-FEA8-4726-91E1-6383D40E391DQ36464075-60E0E75F-387C-433B-BE03-57B1E062CEE5Q36470049-41CB2E0C-B318-4D96-B9D6-52828B00561BQ36625405-8D146E8F-36C8-4683-BCAB-0B539A43EFC5Q36636558-C2F4FE23-1364-4EA0-90AA-2A131FBAEF21Q36661960-83183E59-6AEE-46FD-921B-EACA1AB3D646Q36765997-6E0575B9-C011-4A4E-A0C5-44BBF4253D34Q37157888-EAD37E1C-4B28-4D95-BF84-3211E6336E45Q37558436-BEB399C4-45C8-4EC9-B431-344780C4B805Q38202537-E20C9DFC-4A83-4118-883D-B3D8A34D0152Q38205945-7178813C-6927-4C7D-8E8D-F1EA60284D05Q38232759-9F2A80CC-B0F4-4C5D-B611-91B1CC6CD94EQ38266903-D96B8019-9B0D-47AF-A39E-72DB48555B90Q38379177-99716B2C-53A3-4091-AE90-D6214E6529BDQ38543812-F733C627-B09E-4434-B5B1-D7E4A1F7F9E0Q38642557-7D6A557A-98BA-4643-B805-4110D0404607Q38781015-035312F4-72FB-42E2-ACA7-7538E0F53E83Q38784271-2D751E87-C29C-4B9D-8902-60DC55B07C92Q38801117-473DFED5-00B5-445D-BADE-BDAF34864C20Q38835020-91DA28CA-13CE-4B39-9529-C7DA420B1D32Q38845946-28BC8D54-B64E-4472-AD99-3BD3B380EDB6Q38874997-2564F0F9-DAD9-4AD8-86DB-CA65895191D9Q38904687-85DD80C4-CAAF-43AD-B46A-1A9B25AA21ACQ38961157-5E993EB3-8F34-4BAB-8841-AD79EE4168C1Q39000052-1A8FA7BD-5D58-4F66-80F9-B06482BA552AQ39008991-69A3EF88-D2EA-4BDF-BA0C-975562B093EBQ39063331-3C918793-AB4A-4594-BCEE-5BB089508871Q39065317-5D252FAA-86A3-4B92-96C7-7199D8A4DEDAQ39119140-F8795465-17F0-4539-A27D-1EFD1873D324
P2860
Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-derived tissue factor-po ...... thrombosis in cancer patients.
@en
Tumor-derived tissue factor-po ...... thrombosis in cancer patients.
@nl
type
label
Tumor-derived tissue factor-po ...... thrombosis in cancer patients.
@en
Tumor-derived tissue factor-po ...... thrombosis in cancer patients.
@nl
prefLabel
Tumor-derived tissue factor-po ...... thrombosis in cancer patients.
@en
Tumor-derived tissue factor-po ...... thrombosis in cancer patients.
@nl
P2860
P1433
P1476
Tumor-derived tissue factor-po ...... thrombosis in cancer patients.
@en
P2093
Julia E Geddings
Nigel Mackman
P2860
P304
P356
10.1182/BLOOD-2013-04-460139
P407
P577
2013-06-24T00:00:00Z